Signify and Boston University Produce Report on UV-C Light

LDS 7 CS Signify 400

June 22, 2020

Signify together with the National Emerging Infectious Diseases Laboratories (NEIDL)1 at Boston University in the US have conducted research that validates the effectiveness of Signify’s UV-C light sources on the inactivation of SARS-CoV-2, the virus that causes COVID-19.

Since the start of the SARS CoV-2 pandemic, Dr. Anthony Griffiths, Associate Professor of Microbiology at Boston University School of Medicine and his team have been working on developing tools to support scientific advancement in this field.2 During their research they have treated inoculated material with different doses of UV-C radiation coming from a Signify light source and assessed the inactivation capacity under various conditions. The team applied a dose of 5mJ/cm2, resulting in a reduction of the SARS-CoV-2 virus of 99% in 6 seconds. Based on the data, it was determined that a dose of 22mJ/cmwill result in a reduction of 99.9999% in 25 seconds.3

 “We’re very excited about these findings and hope that this will accelerate the development of products that can help limit the spread of COVID-19,” he added.

Signify is the leader in UV-C light sources and has been at the forefront of UV technology for more than 35 years. It has a proven track record of innovation in UV-C lighting, which is designed, manufactured and installed in line with the highest safety standards.

“Given the potential of the technology to aid the fight against the coronavirus, Signify will not keep the technology for its exclusive use but make it available to other lighting companies. To service the growing need for disinfection we will increase our production capacity multifold in the coming months,” he added.

1 The NEIDL is a state-of-the-art research facility that encompasses significant containment laboratories at Biosafety Level -2, -3, and -4

2 Dr. Griffiths’ team develops vaccines and therapeutics for Risk Group 3 and 4 viruses, which include organisms that can cause serious or deadly diseases in humans

3 Research variables are available upon request

Source

 

Related Articles


Changing Scene

  • Deadline Approaching for DALI Lighting Awards Entries

    November 23, 2022 The DALI Alliance, the global industry organization for DALI lighting control, announces the call for entries for the DALI Lighting Awards 2022. With a closing date of December 2, 2022, the DALI Lighting Awards 2022 will highlight and recognize the best use of DALI control applications and solutions in lighting projects across… Read More…

  • Stanpro EFC Scholarship Recipient for 2022

    November 21, 2022 Ascot Capital Group, Stanpro’s corporate seat, is proud to announce the awarding of its annual scholarship under the Electro-Federation Canada scholarship program for a 5th consecutive year. To be eligible, student applicants must meet specific criteria leading to careers in the electrical industry. The criteria are as follows: Applicants must pursue post-secondary… Read More…


Design


New Products

  • Luminis Launches Clermont Family of Interior and Exterior Luminaires

    Luminis Launches Clermont Family of Interior and Exterior Luminaires

    November 24, 2022 Luminis released its Clermont family of interior and exterior luminaires. Clermont offers multiple mounting options and optics to meet a variety of lighting needs. Clermont was designed with a “curb to cube” family approach. Designers can mix and match optic requirements and mounting options to create a consistent design aesthetic and carry… Read More…

  • Edison Sonic Drum+ with BIOS SkyBlue

    The Sonic Drum+ with BIOS SkyBlue by Edison Lighting features an architectural acoustic luminaire with direct lighting distribution.

     

     

    Read More…